Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Biol Trace Elem Res ; 199(2): 660-667, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32328969

ABSTRACT

We aimed to investigate the effects of two different chronic immobilization stress protocols on depression-related behaviors and brain mineral levels. Adult female Wistar albino rats were divided into 3 groups as follows (n = 10/group): control, immobilization stress-1 (45 min daily for 7 days), and immobilization stress-2 (45 min twice a day for 7 day). Stress-related behavior was evaluated by means of the forced swimming test (FST) and open field test (OFT). Minerals were analyzed using an inductively coupled plasma mass spectrometer. In the FST, swimming and immobility were significantly lower in the immobilization stress-1 and immobilization stress-2 groups. The climbing duration of the immobilization stress-2 group was higher than the control group. In the OFT, percentage of time spent in the central area was significantly lower in the immobilization stress-1 and immobilization stress-2 groups. Values of latency to center area, rearing, and grooming did not significantly differ between groups. In the immobilization stress-1 group, zinc was lower, and iron, copper, and manganese were higher than the control group. In the immobilization stress-2 group, copper and manganese were higher, and phosphate was lower than the control group. Our results showed that depression-related behaviors were more dominant in the immobilization stress-1 group. A decrease in the brain zinc level was valid only for the immobilization stress-1 group. These results point to the role of low brain zinc levels in the pathophysiology of depression.


Subject(s)
Depression , Swimming , Animals , Behavior, Animal , Brain , Female , Minerals , Rats , Rats, Wistar , Stress, Psychological
2.
Curr HIV Res ; 18(4): 258-266, 2020.
Article in English | MEDLINE | ID: mdl-32342820

ABSTRACT

OBJECTIVE: The aim of this study was to analyze the temporal trends of HIV epidemiology in Turkey from 2011 to 2016. METHODS: Thirty-four teams from 28 centers at 17 different cities participated in this retrospective study. Participating centers were asked to complete a structured form containing questions about epidemiologic, demographic and clinical characteristics of patients presented with new HIV diagnosis between 2011 and 2016. Demographic data from all centers (complete or partial) were included in the analyses. For the cascade of care analysis, 15 centers that provided full data from 2011 to 2016 were included. Overall and annual distributions of the data were calculated as percentages and the Chi square test was used to determine temporal changes. RESULTS: A total of 2,953 patients between 2011 and 2016 were included. Overall male to female ratio was 5:1 with a significant increase in the number of male cases from 2011 to 2016 (p<0.001). The highest prevalence was among those aged 25-34 years followed by the 35-44 age bracket. The most common reason for HIV testing was illness (35%). While the frequency of sex among men who have sex with men increased from 16% to 30.6% (p<0.001) over the study period, heterosexual intercourse (53%) was found to be the most common transmission route. Overall, 29% of the cases presented with a CD4 count of >500 cells/mm3 while 46.7% presented with a CD4 T cell count of <350 cells/mm3. Among newly diagnosed cases, 79% were retained in care, and all such cases initiated ART with 73% achieving viral suppression after six months of antiretroviral therapy. CONCLUSION: The epidemiologic profile of HIV infected individuals is changing rapidly in Turkey with an increasing trend in the number of newly diagnosed people disclosing themselves as MSM. New diagnoses were mostly at a young age. The late diagnosis was found to be a challenging issue. Despite the unavailability of data for the first 90, Turkey is close to the last two steps of 90-90-90 targets.


Subject(s)
HIV Infections/epidemiology , HIV/pathogenicity , Hepacivirus/pathogenicity , Hepatitis B virus/pathogenicity , Hepatitis B/epidemiology , Hepatitis C/epidemiology , Adolescent , Adult , Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/virology , Child , Child, Preschool , Coinfection , Delayed Diagnosis , Female , HIV/drug effects , HIV/physiology , HIV Infections/drug therapy , HIV Infections/mortality , HIV Infections/virology , Hepacivirus/drug effects , Hepacivirus/physiology , Hepatitis B/drug therapy , Hepatitis B/mortality , Hepatitis B/virology , Hepatitis B virus/drug effects , Hepatitis B virus/physiology , Hepatitis C/drug therapy , Hepatitis C/mortality , Hepatitis C/virology , Heterosexuality/statistics & numerical data , Homosexuality, Male/statistics & numerical data , Humans , Incidence , Infant , Male , Middle Aged , Retrospective Studies , Survival Analysis , Turkey/epidemiology , Viral Load/drug effects
3.
Neurosci Lett ; 690: 120-125, 2019 01 18.
Article in English | MEDLINE | ID: mdl-30213622

ABSTRACT

Agomelatine is a new antidepressant drug acting as an antagonist of 5-hydroxytryptamine receptor 2C (5-HTR2C) and agonist of melatonergic receptors 1 and 2 (MT1 and MT2). Because of this dual action, it is an atypical antidepressant. The aim of this study was to investigate chronic anticonvulsant effects of agomelatine on penicillin-induced epilepsy model. Adult male Sprague-Dawley rats divided into four groups and were administered with tap water (vehicle), and agomelatine doses of 10 mg/kg, 50 mg/kg and 100 mg/kg for 14 days via oral gavage. After the last doses were given, epileptic seizures were induced by intracortical penicillin (500 IU/2.5 µl) application in rats under urethane (1.25 g/kg intraperitoneal) anesthesia. Electrocorticogram (ECoG) recordings were obtained from the somatomotor cortex through 90 min, and spike frequencies and amplitudes were analyzed. The spike frequency analyses revealed that only 50 mg/kg agomelatine administration decreased the spike frequencies of hypersynchronous discharge of neurons caused by penicillin (p < 0.05). No significant differences in amplitudes between experimental groups were observed. In addition, mRNA expressions of vesicular glutamate transporter 1 (VGLUT1) and vesicular gamma-aminobutyric acid transporter (VGAT) in response to the agomelatine active dose, 50 mg/kg, showed no significant effect of agomelatine on the mRNA expression. Our results indicate that chronic treatment with agomelatine may have potential anticonvulsant effects. Agomelatine may be a promising drug for epilepsy patients having depression due to its antiepileptic and antidepressant effects.


Subject(s)
Acetamides/pharmacology , Electrocorticography/drug effects , Penicillins/pharmacology , Seizures/prevention & control , Animals , Dose-Response Relationship, Drug , Gene Expression/drug effects , Male , Microinjections , Motor Cortex/metabolism , Motor Cortex/physiopathology , Rats , Seizures/chemically induced , Seizures/physiopathology , Vesicular Glutamate Transport Protein 1/biosynthesis , Vesicular Inhibitory Amino Acid Transport Proteins/biosynthesis
4.
Physiol Int ; 104(3): 226-234, 2017 Sep 01.
Article in English | MEDLINE | ID: mdl-28956637

ABSTRACT

Statins have cholesterol-independent effects including an increased vascular nitric oxide activity and are commonly used by patients with cardiovascular disease. Such patients frequently have cardiovascular diseases, which may be treated with cilostazol, a platelet aggregation inhibitor. This study was designed to investigate whether combined use of cilostazol would increase the inhibitory effect of statin on vascular smooth muscle and how maturation would affect these responses. Female Wistar rats, aged 3-4 months (young) and 14-15 months (adult), were sacrificed by cervical dislocation and the thoracic aorta was dissected and cut into 3- to 4-mm-long rings. The rings were mounted under a resting tension of 1 g in a 20-ml organ bath filled with Krebs-Henseleit solution. Rings were precontracted with phenylephrine (10-6 M), and the presence of endothelium was confirmed with acetylcholine (10-6 M). Then, the concentration-response curves were obtained for atorvastatin alone (10-10 to 3 × 10-4 M; control) and in the presence of cilostazol (10-6 M) in young and adult rat aortas. This experimental protocol was also carried out in aorta rings, which had been pretreated with NG-nitro-l-arginine methyl ester (l-NAME, 10-4 M). Atorvastatin induced concentration-dependent relaxations in young and adult rat thoracic aorta rings precontracted with phenylephrine. The pIC50 value of atorvastatin was significantly decreased in adult rat aortas. In addition, pretreatment of aortas with cilostazol enhanced the potency of atorvastatin in both young and adult aortas. Incubation with l-NAME did not completely eliminate the relaxations to atorvastatin in the presence of cilostazol. These results suggest that combined application of cilostazol with atorvastatin was significantly more potent than atorvastatin alone. Combined drug therapy may be efficacious in delaying the occurrence of cardiovascular events.


Subject(s)
Aging/physiology , Aorta/drug effects , Aorta/physiology , Atorvastatin/administration & dosage , Tetrazoles/administration & dosage , Animals , Cilostazol , Dose-Response Relationship, Drug , Drug Combinations , Drug Synergism , Female , In Vitro Techniques , Rats , Rats, Wistar , Treatment Outcome , Vasodilator Agents/administration & dosage
5.
HIV Clin Trials ; 17(3): 109-13, 2016 05.
Article in English | MEDLINE | ID: mdl-27125365

ABSTRACT

OBJECTIVES: Integrase strand transfer inhibitor (INSTI) is a new class of antiretroviral (ARV) drugs designed to block the action of the integrase viral enzyme, which is responsible for insertation of the HIV-1 genome into the host DNA. The aim of this study was to evaluate for the first time INSTI resistance mutations in Turkish patients. METHODS: This study was conducted in Turkey, between April 2013 and April 2015 using 169 HIV-1-infected patients (78 ARV naive patients and 91 ARV-experienced patients). Laboratory and clinical characteristics of ARV naive and ARV-experienced patients were as follows: gender (M/F): 71/7 and 80/11, median age: 38 and 38.4; median CD4(+) T-cell: 236 and 216 cells/mm(3), median HIV-1 RNA: 4.95+E5 and 1.08E+6 copies/ml. Population-based seqeunces of the reverse transcriptase, protease, and integrase domains of the HIV-1 pol gene were used to detect HIV-1 drug resistance mutations. RESULT: INSTI resistance mutations were not found in recently diagnosed HIV-1-infected patients. However, ARV-experienced patients had major resistance mutations associated with raltegravir and elvitegravir; the following results were generated:F121Y, Y143R, Q148R and E157Q (6/91 - 6.6%). CONCLUSIONS: The prevalence of INSTI resistant mutations in ART-experienced patients suggested that resistance testing must be incorporated as an integral part of HIV management with INSTI therapies.


Subject(s)
Drug Resistance, Viral , HIV Infections/drug therapy , HIV Infections/virology , HIV Integrase Inhibitors/therapeutic use , HIV-1/drug effects , HIV-1/genetics , Mutation , Adult , Aged , Amino Acid Substitution , CD4 Lymphocyte Count , Codon , Coinfection , Female , Genotype , HIV Infections/transmission , HIV Integrase Inhibitors/pharmacology , Humans , Male , Microbial Sensitivity Tests , Middle Aged , RNA, Viral , Risk Factors , Turkey , Viral Load , Young Adult
6.
Andrologia ; 48(4): 453-63, 2016 May.
Article in English | MEDLINE | ID: mdl-26276507

ABSTRACT

We investigated the therapeutic effects of valproic acid (VPA) on erectile dysfunction and reducing penile fibrosis in streptozocin (STZ)-induced diabetic rats. Eighteen male rats were divided into three experimental groups (Control, STZ-DM, STZ-DM plus VPA) and diabetes was induced by transperitoneal single dose STZ. Eight weeks after, VPA and placebo treatments were given according to groups for 15 days. All rats were anesthetised for the measurement of in vivo erectile response to cavernous nerve stimulation. Afterward penes were evaluated histologically in terms of immune labelling scores of endothelial nitric oxide synthase (eNOS), vascular endothelial growth factor (VEGF) and transforming growth factor-ß1 (TGF-ß1). Slides were also evaluated in terms of collagen/smooth muscle ratio and penile apoptosis. After the treatment with VPA, erectile responses were found as improved when compared with STZ-DM rats but not statistically meaningful. eNOS and VEGF immune expressions diminished in penile corpora of STZ-DM rats and improved with VPA treatment. VPA led to decrease in TGF-ß1 expression and collagen content of diabetic rats' penes. Penile apoptosis was not diminished with VPA. In conclusion, VPA treatment seems to be effective for reducing penile fibrosis in diabetic rats and more prolonged treatment period may enhance erectile functions.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Erectile Dysfunction/drug therapy , Penile Induration/drug therapy , Penis/drug effects , Valproic Acid/therapeutic use , Animals , Apoptosis/drug effects , Diabetes Mellitus, Experimental/chemically induced , Erectile Dysfunction/metabolism , Humans , Injections, Intraperitoneal , Male , Nitric Oxide Synthase Type III/metabolism , Penile Erection/drug effects , Penis/metabolism , Penis/pathology , Rats , Rats, Sprague-Dawley , Streptozocin/administration & dosage , Streptozocin/toxicity , Transforming Growth Factor beta1/metabolism , Vascular Endothelial Growth Factor A/metabolism
7.
Clin Microbiol Infect ; 19(3): E136-41, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23331540

ABSTRACT

We aimed to establish that a bronchoscopic view can be as reliable as microbiology, and support an empirical tracheobronchial fungal infection (TBFI) treatment decision. We retrospectively studied 95 respiratory failure patients with suspected TBFI admitted to the intensive-care unit (ICU) in 2008 with sticky secretions, hyperaemic mucosa, and whitish plaques on bronchoscopic view. Patients not suspected of having TBFI were chosen as a control group (n = 151). Broncheoalveolar lavage (BAL) fluid was cultured, and biopsy samples were taken from the lesions. Biopsy samples positive for fungi were defined as 'proven', only BAL-positive (+ fungi) cases were 'probable TBFI', and BAL-negative (- fungi) cases were 'possible TBFI'. BAL (+ fungi) and BAL (- fungi) in the control group were defined as 'colonization' and 'no TBFI', respectively. The sensitivity, specificity and positive and negative predictive values of BAL (+ fungi) were 85.1% (63/74), 81.4% (140/172), 66.3% (63/95), and 92.7% (140/151), respectively. Biopsies were performed in 78 of 95 patients, and 28 were proven TBFI with fungal elements, and 100% were BAL (+ fungi). Probable TBFI was seen in 30 of 95 patients with BAL (+ fungi), and possible TBFI (BAL(- fungi)) in 25 of 95. Among the 95 patients, microbiology revealed fungi (90.5% Candida species; 9.5% Aspergillus) in 63 (66.3%). In the controls, the colonization and no TBFI rates were 11 of 151 and 140 of 151, respectively. Observing sticky secretions, hyperaemic mucosa and whitish plaques by bronchoscopy is faster than and may be as reliable as microbiology for diagnosing TBFI. These findings are relevant for empirical antifungal therapy in suspected TBFI patients in the ICU.


Subject(s)
Bronchoscopy/methods , Mycoses/diagnosis , Respiratory Tract Infections/diagnosis , Aged , Biopsy , Bronchoalveolar Lavage Fluid/microbiology , Case-Control Studies , Female , Fungi/classification , Fungi/isolation & purification , Humans , Intensive Care Units , Male , Middle Aged , Mycoses/pathology , Predictive Value of Tests , Respiratory Tract Infections/pathology , Retrospective Studies , Sensitivity and Specificity
8.
Zoonoses Public Health ; 59(6): 445-9, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22489645

ABSTRACT

Bartonella henselae infections are usually detected among people who have close contact with animals. Veterinarians and cattle breeders, in particular, are considered as the risk groups for B. henselae infections. In this study, the seroprevalence of antibodies to B. henselae was investigated in these two groups of subjects in the two cities of Aydin and Denizli, which are located in the same region in the southwest of Turkey. Total antibodies to B. henselae were evaluated by indirect immunofluorescence assay in serum samples taken from 63 cattle breeders and 27 veterinarians. Twenty samples (22.2%) were found to react on 1/64 titre with B. henselae antigens. Bartonella henselae seroprevalence was found to be significantly related to age (P = 0.033) and higher in those living in Aydin (P = 0.047). Age was the only independent factor in multivariate analysis (P = 0.008). Seroprevalence was found to be 2-fold higher in those people who had had tick contact (P = 0.093). In conclusion, the physicians in the region should consider B. henselae infection among veterinarians and breeders in their differential diagnosis list of fever of unknown origin.


Subject(s)
Antibodies, Bacterial/blood , Bartonella Infections/epidemiology , Bartonella henselae/immunology , Occupational Diseases/epidemiology , Occupational Exposure , Adult , Animal Husbandry , Animals , Antigens, Bacterial/immunology , Bartonella Infections/microbiology , Bartonella henselae/isolation & purification , Cattle , Demography , Female , Humans , Male , Occupational Diseases/microbiology , Risk Factors , Seroepidemiologic Studies , Surveys and Questionnaires , Turkey/epidemiology , Veterinarians/statistics & numerical data
9.
J Hosp Infect ; 80(4): 326-30, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22365915

ABSTRACT

BACKGROUND: Laboratory healthcare workers (HCWs) are at risk of laboratory-acquired brucellosis (LAB). AIM: To describe the risk factors of LAB among HCWs. METHODS: A multicentre survey study was conducted by face-to-face interview in 38 hospitals from 17 provinces of Turkey. A structured survey was administered to the HCWs, working in infectious diseases clinics and microbiology departments, who were at risk of brucella infection. FINDINGS: The survey response rate was 100%. Of the 667 laboratory workers, 38 (5.8%) had a history of LAB. In multivariate analysis, factors independently associated with an increased risk of LAB included working with the brucella bacteria (odds ratio: 5.12; 95% confidence interval: 2.28-11.52; P < 0.001) and male gender (2.14; 1.02-4.45; P = 0.042). Using a biosafety cabinet level 2 (0.13; 0.03-0.60; P = 0.009), full adherence to glove use (0.27; 0.11-0.65; P = 0.004) and longer duration of professional life (0.86; 0.80-0.92; P < 0.001) were found to be protective. CONCLUSIONS: Working with the brucella bacteria, being male, a lack of compliance with personal protective equipment and biosafety cabinets were the independent risk factors for the development of LAB in our series. Increased adherence to personal protective equipment and use of biosafety cabinets should be priority targets to prevent LAB.


Subject(s)
Brucellosis/epidemiology , Health Personnel , Laboratories, Hospital , Occupational Diseases/epidemiology , Occupational Exposure , Adult , Attitude of Health Personnel , Female , Guideline Adherence/statistics & numerical data , Humans , Male , Middle Aged , Risk Factors , Turkey
10.
Epidemiol Infect ; 138(5): 697-701, 2010 May.
Article in English | MEDLINE | ID: mdl-19878612

ABSTRACT

We analysed nosocomial MRSA cases between January 2004 and December 2006 in a retrospective case-control study in a 250-bed tertiary-care teaching hospital. During the study period, 265 nosocomial Staphylococcus aureus infections were identified in 231 patients. There was a significant increase in methicillin resistance in isolates (MRSA) from these infections with frequencies for 2004 of 39/88 (44.3%), 2005 (62/80, 77.5%), and 2006 (75/97, 77.3%) (P<0.001). Multivariate analysis showed that associated factors for nosocomial MRSA infection were prolonged hospitalization (OR 3.982, 95% CI 2.235-7.094, P<0.001), mechanical ventilation (OR 3.052, 95% CI 1.666-5.590, P<0.001), surgical operation (OR 2.032, 95% CI 1.102-3.748, P=0.023), and male sex (OR 2.000, 95% CI 1.081-3.699, P=0.027). The determination of associated factors for methicillin resistance in nosocomial S. aureus infections in hospitals will play an important role in efforts to reduce MRSA infection rates.


Subject(s)
Cross Infection/epidemiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Child , Child, Preschool , Cross Infection/microbiology , Female , Hospitals , Humans , Infant , Infant, Newborn , Length of Stay , Male , Middle Aged , Respiration, Artificial , Retrospective Studies , Risk Factors , Sex Factors , Staphylococcal Infections/microbiology , Surgical Procedures, Operative , Young Adult
11.
J. physiol. biochem ; 65(3): 267-275, sept. 2009.
Article in English | IBECS | ID: ibc-122871

ABSTRACT

No disponible


We aimed to investigate the effects of the aromatase inhibitor letrozole on femur fracture and serum levels of alkaline phosphatase (ALP), calcium and phosphate in female rats. Intact 32 Sprague-Dawley female rats were divided into four groups (n=8): control, letrozole 0.2 , letrozole 1 (treatment of 0.2 and 1 mg/kg for six weeks) and recovery (letrozole-treated 1 mg/kg for six weeks then allowed to recover for two weeks). Besides, 24 ovariectomized rats were divided into three groups (n=8): ovariectomized+control, ovariectomized+letrozole and ovariectomized+letrozole+ estradiol (10 ìg/rat). After experimental period, rats’ femur bones were removed for biomechanical studies following decapitation. Serum ALP, calcium and phosphate were measured. Biomechanical values, ALP and phosphate significantly increased by letrozole in a dose-dependent manner (p<0.05) while calcium levels and net bone area decreased (p<0.05). Ultimate strength was positively correlated with ALP and phosphate and negatively correlated with calcium. The results indicate that letrozole may increase risk of bone fracture and affect bone biomarkers such as ALP, calcium and phosphate in both intact and ovariectomized rats (AU)


Subject(s)
Animals , Female , Rats , Aromatase Inhibitors/pharmacokinetics , Femoral Fractures , Alkaline Phosphatase , Calcium/blood , Phosphates/blood , Ovariectomy , Risk Factors
12.
J Physiol Biochem ; 65(3): 267-75, 2009 Sep.
Article in English | MEDLINE | ID: mdl-20119821

ABSTRACT

We aimed to investigate the effects of the aromatase inhibitor letrozole on femur fracture and serum levels of alkaline phosphatase (ALP), calcium and phosphate in female rats. Intact 32 Sprague-Dawley female rats were divided into four groups (n=8): control, letrozole 0.2 , letrozole 1 (treatment of 0.2 and 1 mg/kg for six weeks) and recovery (letrozole-treated 1 mg/kg for six weeks then allowed to recover for two weeks). Besides, 24 ovariectomized rats were divided into three groups (n=8): ovariectomized+control, ovariectomized+letrozole and ovariectomized+letrozole+ estradiol (10 microg/rat). After experimental period, rats' femur bones were removed for biomechanical studies following decapitation. Serum ALP, calcium and phosphate were measured. Biomechanical values, ALP and phosphate significantly increased by letrozole in a dose-dependent manner (p<0.05) while calcium levels and net bone area decreased (p<0.05). Ultimate strength was positively correlated with ALP and phosphate and negatively correlated with calcium. The results indicate that letrozole may increase risk of bone fracture and affect bone biomarkers such as ALP, calcium and phosphate in both intact and ovariectomized rats.


Subject(s)
Aromatase Inhibitors/pharmacology , Bone and Bones/drug effects , Femoral Fractures/chemically induced , Nitriles/pharmacology , Triazoles/pharmacology , Alkaline Phosphatase/blood , Animals , Biomarkers/blood , Biomechanical Phenomena/drug effects , Calcium/blood , Estradiol/pharmacology , Female , Letrozole , Ovariectomy , Phosphates/blood , Rats , Rats, Sprague-Dawley
14.
Acta Anaesthesiol Scand ; 52(7): 926-30, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18477089

ABSTRACT

BACKGROUND AND OBJECTIVE: Despite important advances in available knowledge, management of neuropathic pain remains incomplete, and results from experimental and clinical studies indicate that some anticonvulsants show promise for treating neuropathic pain. The aim of this study was to assess the antinociceptive efficacy of levetiracetam (LEV, ucb L059) in a mice model for painful diabetic neuropathy using the in vivo nociceptive behavioral 'hot-plate test.' METHODS: The hot-plate test consisted of placing individual mice (adult male Balb/C) on the hot plate at 50+/-0.1 degrees C and timing the delay for the first hind paw lift (nociceptive threshold). After obtaining control values, diabetes was induced by injection of streptozotocin [200 mg/kg intraperitoneally (i.p.)] and 2 weeks after induction of diabetes (serum glucose > or =400 mg/dL) LEV was administered i.p. and hot-plate tests were repeated. Pain threshold values were determined and analyzed by Kruskal-Wallis one-way analysis of variance (ANOVA) followed by a pairwise comparison using a Dunnett's t-test on the ranked data. RESULTS: LEV (60, 300 and 900 mg/kg) had no significant effect on the nociceptive threshold in normal mice (n=8 for each dose, P>0.05). There were significant decreases in pain threshold latency in diabetic mice compared with the normal healthy group and these were significantly and dose-dependently restored by much lower doses of LEV (20, 100 and 200 mg/kg) in a reversible manner. CONCLUSION: Results obtained from the in vivo behavioral test lend support to the validation of the promising therapeutic potential of the novel antiepileptic agent LEV in the treatment of neuropathic pain.


Subject(s)
Analgesics/therapeutic use , Anticonvulsants/therapeutic use , Diabetic Neuropathies/drug therapy , Pain/drug therapy , Piracetam/analogs & derivatives , Animals , Behavior, Animal/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Hot Temperature , Levetiracetam , Male , Mice , Mice, Inbred BALB C , Pain Measurement/methods , Pain Measurement/statistics & numerical data , Piracetam/therapeutic use , Time Factors , Treatment Outcome
15.
Infection ; 36(3): 262-5, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18454338

ABSTRACT

Intensive care units (ICUs) are unfortunately the epicenters of nosocomial infections. The aim of the study was to investigate device associated infection rates in a small Turkish hospital. Device utilization ratios and device associated infection rates were calculated according to definitions of the Centers for Disease Control (CDC). During a period of 24 months 1,387 patients were surveyed in our ICUs. A total of 287 device associated infections were detected. In our study ventilator associated pneumonia was the most frequent nosocomial infection with a rate of 59.7 per 1,000 ventilator days. The most frequent pathogen of device associated infection was Candida spp. High rates of device associated infections in a small Turkish hospital clearly indicate the urgent need of the implementation of infection control guidelines.


Subject(s)
Catheterization, Central Venous/adverse effects , Cross Infection/epidemiology , Hospitals, University , Intensive Care Units , Pneumonia, Ventilator-Associated/epidemiology , Urinary Catheterization/adverse effects , Bacteremia/epidemiology , Bacteremia/microbiology , Candida/classification , Candida/isolation & purification , Candidiasis/epidemiology , Candidiasis/microbiology , Cross Infection/microbiology , Gram-Negative Bacteria/classification , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/epidemiology , Gram-Negative Bacterial Infections/microbiology , Humans , Intensive Care Units/statistics & numerical data , Pneumonia, Ventilator-Associated/microbiology , Turkey/epidemiology , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology
16.
Cardiovasc J S Afr ; 18(1): 34-5, 2007.
Article in English | MEDLINE | ID: mdl-17392994

ABSTRACT

To cut costs, many centres around the world utilise previously used, re-sterilized balloon catheters to perform coronary angioplasty. The fracture and lodging of an angioplasty device within the coronary arteries is a rare but increasingly noted complication. In this article, we report on the inadvertent retrieval of a coronary angioplasty catheter during off-pump coronary bypass. The accidental removal of the catheter, which extended to the descending aorta, has obviously been life saving. This experience has shown that a high degree of caution is required when planning an operation for the retrieval of PTCA hardware.


Subject(s)
Angioplasty, Balloon, Coronary/instrumentation , Aorta, Thoracic/surgery , Coronary Artery Bypass, Off-Pump , Device Removal/instrumentation , Coronary Stenosis/therapy , Foreign-Body Migration/etiology , Humans , Male , Middle Aged
17.
Cardiovasc J S Afr ; 18(1): 26-9, 2007.
Article in English | MEDLINE | ID: mdl-17392992

ABSTRACT

BACKGROUND: In this study the results of off-pump bypass in patients with advanced left ventricular dysfunction (LVD) and without bypassable circumflex disease were analysed retrospectively. METHODS: Fifty-five patients with advanced LVD underwent off-pump coronary bypass. Their ages ranged from 39 to 82 years (mean 62.3 +/- 8.4). Forty-two of the patients (76.3%) were in NYHA class III or IV. Mean left ventricular ejection fraction (LVEF) was 23.8 +/- 5.1%. Pre- and intra-operative variables, and postoperative complications and mortality of the patients were analysed. Mid-term follow-up was done by telephone either with the referring cardiologist or the patients. RESULTS: The mean number of coronary artery bypass grafts (CABG) per patient was 2.22 +/- 0.63. Eight coronary endarterectomies were achieved; early mortality was 3.6%. Pre-operative myocardial infarction (MI) occurred in one patient (1.8%). Two patients (3.6%) were supported with an intra-aortic balloon pump (IABP) and 10 (18.1%) needed inotropic support. Mean postoperative blood loss was 425 +/- 50 cm3. A significant improvement in ejection fraction was observed in the postoperative course. Mean intensive care unit stay was 2.1 +/- 1.1 days and mean hospital stay was 7.2 +/- 1.3 days. The mean follow-up period was 21.8 +/- 6.2 months and mid-term survival was 2.4%. Freedom from cardiac events requiring hospital admission was 89.7%. Most of the patients enjoyed symptomatic relief, however 16 patients (32.6% of survivors) remained in NYHA class III. CONCLUSION: These results support the effectiveness of off-pump coronary bypass with good early and mid-term results in patients with ischaemic cardiomyopathy and without bypassable circumflex lesion.


Subject(s)
Coronary Artery Bypass, Off-Pump , Ventricular Dysfunction, Left/surgery , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Intraoperative Period , Length of Stay , Male , Middle Aged , Morbidity , Postoperative Period , Retrospective Studies , Stroke Volume , Survival Analysis , Time Factors , Treatment Outcome , Ventricular Dysfunction, Left/epidemiology , Ventricular Dysfunction, Left/physiopathology
18.
J Cardiothorac Surg ; 1: 44, 2006 Nov 16.
Article in English | MEDLINE | ID: mdl-17109751

ABSTRACT

BACKGROUND: The outcomes of on-pump and hybrid-pump bypass surgery in patients with depressed left ventricular function (EF<30%) were analyzed. METHODS: 109 patients with preoperative left ventricular ejection fraction of <30% and bypassable circumflex coronary disease were randomized in a double blind fashion to undergo hybrid-pump (combination of off-pump and on-pump) procedure (54 patients), or on-pump coronary bypass (55 patients). In patients who underwent hybrid-pump procedure only circumflex system was bypassed on-pump to shorten CPB and myocardial ischemic time. Pre- peri and postoperative variables were analyzed. RESULTS: Mean LVEF 24.4 +/- 4.8%. The patients in hybrid-pump group received less graft than others, but difference was not significant. Duration of the surgery was not different statistically between hybrid-pump and on-pump groups. A longer intraoperative duration of ischemia and extra corporeal circulation was found in on-pump group. Significant improvement in the postoperative course such as shorter mechanical ventilation, less catecholamines and IABP usage, less ICU and hospital stay, less stroke, less need for hemodyalisis and most importantly less hospital mortality was observed in hybrid-pump group. CONCLUSION: Shortening the CPB and myocardial ischemic time and avoiding related problems, adoption of hybrid-pump strategy, in patients with severely impaired LVEF and bypassable circumflex coronary disease results in better outcome than conventional on-pump bypass.


Subject(s)
Coronary Artery Bypass/methods , Ventricular Dysfunction, Left/surgery , Aged , Double-Blind Method , Female , Humans , Male , Middle Aged
19.
Mikrobiyol Bul ; 40(3): 265-8, 2006 Jul.
Article in Turkish | MEDLINE | ID: mdl-17001857

ABSTRACT

Although Brucella species are susceptible to many antimicrobial agents in vitro, the susceptibility tests for these bacteria are not well standardized and the break point values are not described yet clearly. The aim of this study was to investigate the minimum inhibitory concentration (MIC) values of 43 Brucella strains isolated from blood cultures by E-test. Streptomycin and rifampicin E-tests were performed for all of the strains, however, tetracycline and ciprofloxacin were tested for only 27 and 17 strains, respectively. The MIC interval for streptomycin was 0.025-1 mg/L, for rifampicin 0.19-1.5 mg/L, for tetracycline <0.016-0.032 mg/L, and for ciprofloxacin 0.094-0.64 mg/L. One strain was found intermediately susceptible to rifampicin. In may be concluded that development of resistance is not eligible against antibiotics which are currently used for brucellosis therapy.


Subject(s)
Anti-Bacterial Agents/pharmacology , Brucella/drug effects , Ciprofloxacin/pharmacology , Rifampin/pharmacology , Streptomycin/pharmacology , Tetracycline/pharmacology , Humans , Microbial Sensitivity Tests
20.
Circ J ; 70(8): 1048-51, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16864940

ABSTRACT

BACKGROUND: The effectiveness and advantages of off-pump coronary artery bypass (OPCAB) for patients with concomitant malignant neoplastic disorders were analyzed. METHODS AND RESULTS: The study group comprised 368 patients who underwent OPCAB and of them 18 had concomitant malignant neoplastic disease: 14 with solitary malignant disease, 4 with low-grade lymphocytic malignancies. The age of the patients ranged from 49 to 72 years (mean 61). The mean left ventricular ejection fraction was 46.4% (range: 35-60%) and the mean number of grafts was 2.4+/-0.9. The left internal mammary artery was used in 12 patients (75%). Mean blood loss was 420+/-64 ml and the average requirement for blood transfusion was 1.1+/-0.2 units. There was no postoperative infection or in-hospital mortality. The mean length of hospital stay was 6.4+/-1.3 days. Mid-term follow-up was completed (100%) and the mean follow-up period was 22.6+/-4.1 months. All patients with a solitary malignancy underwent subsequent non-cardiac surgery with a mean interval of 16.4+/-3.3 days. Mid-term survival was 83.4%. Freedom from late cardiac events (angina, myocardial infarction, percutaneous transluminal coronary angioplasty) that required hospital admission was 92.3%. CONCLUSION: These results support the effectiveness of OPCAB, mostly as a bridge to safe non-cardiac surgery that can be crucial for long-term survival.


Subject(s)
Coronary Artery Bypass, Off-Pump/methods , Coronary Artery Disease/surgery , Neoplasms/pathology , Aged , Coronary Artery Bypass, Off-Pump/statistics & numerical data , Coronary Artery Disease/physiopathology , Female , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Postoperative Complications , Postoperative Hemorrhage , Retrospective Studies , Stroke Volume/physiology , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...